NYSE: AXRAmrep Corp Stock
$20.93+0.02 (+0.1%)
Updated Oct 23, 2026
AXR Price
$20.93
Fair Value Price
N/A
Market Cap
$111.45M
52 Week Low
$17.61
52 Week High
$29.00
P/E
19.03x
P/B
0.79x
P/S
3.02x
PEG
1.44x
Dividend Yield
N/A
Revenue
$41.05M
Earnings
$5.87M
Gross Margin
38.2%
Operating Margin
14.82%
Profit Margin
14.3%
Debt to Equity
0.03
Operating Cash Flow
-$281k
Beta
0.48
Next Earnings
Dec 11, 2026
Ex-Dividend
N/A
Next Dividend
N/A
AXR Overview
AMREP Corporation is a real estate and media services company. The company sells developed and undeveloped lots to homebuilders, commercial and industrial property developers, and others. The company owns tracts of land in Colorado, and subsurface oil, gas, and mineral in Rio Rancho. AMREP also develops single-family detached homes and attached townhomes. The company was founded in 1961 and is based in Princeton, NJ.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AXR's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -6.47% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Real Estate Development
Industry Rating
F
AXR
Ranked#6 of 7
Ranked#6 of 7
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $4.20 | C | |
| $36.34 | C | |
| $26.09 | C |
Be the first to know about important AXR news, forecast changes, insider trades & much more!
AXR News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AXR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AXR ($20.93) is trading above its intrinsic value of $9.58, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AXR is good value based on its earnings relative to its share price (19.03x), compared to the US market average (46.1x)
P/E vs Market Valuation
AXR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more AXR due diligence checks available for Premium users.
Valuation
AXR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
19.03x
Industry
39.95x
Market
46.1x
AXR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
AXR is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
AXR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.79x
Industry
0.95x
AXR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AXR price to earnings growth (PEG)
For valuing profitable companies with growth potential
AXR is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
AXR's financial health
Profit margin
Revenue
$6.1M
Net Income
$276.0k
Profit Margin
4.6%
AXR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$145.7M
Liabilities
$4.5M
Debt to equity
0.03
AXR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AXR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$3.6M
Investing
-$4.0k
Financing
-$1.0k
AXR vs Real Estate Development Stocks
Amrep Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.